Chidamide Plus Post-transplantation Cyclophosphamide and Cyclosporine to Prevent Graft-versus-host Disease After Myeloablative Conditioning, Matched Peripheral-blood Stem-cell Transplantation
Latest Information Update: 05 Nov 2021
At a glance
- Drugs Tucidinostat (Primary) ; Ciclosporin; Ciclosporin; Cyclophosphamide
- Indications Graft-versus-host disease
- Focus Therapeutic Use
- 17 Jul 2018 Planned initiation date changed from 1 Jan 2018 to 1 Jan 2019.
- 14 Nov 2017 New trial record